DDX31 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.149000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.670000E-01
Normal-vs-Stage2
8.755600E-01
Normal-vs-Stage3
1.960000E-01
Normal-vs-Stage4
6.143000E-01
Stage1-vs-Stage2
5.223200E-01
Stage1-vs-Stage3
4.761900E-02
Stage1-vs-Stage4
8.888800E-01
Stage2-vs-Stage3
3.506000E-02
Stage2-vs-Stage4
7.028800E-01
Stage3-vs-Stage4
6.432200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.238200E-01
Normal-vs-AfricanAmerican
7.244600E-01
Normal-vs-Asian
6.711000E-01
Caucasian-vs-AfricanAmerican
9.399000E-01
Caucasian-vs-Asian
8.777600E-01
AfricanAmerican-vs-Asian
9.607800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.509000E-01
Normal-vs-Female
7.781400E-01
Male-vs-Female
4.714400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.012600E-01
Normal-vs-Age(41-60Yrs)
4.585800E-01
Normal-vs-Age(61-80Yrs)
9.633000E-01
Normal-vs-Age(81-100Yrs)
7.444200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.612200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.050000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.750400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.402300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.230800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.671600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.550000E-01
Normal-vs-Daily Drinker
9.829200E-01
Normal-vs-Weekly Drinker
9.049400E-01
Normal-vs-Occasional Drinker
5.680000E-01
Normal-vs-Social Drinker
3.366200E-01
Non Drinker-vs-Daily Drinker
9.253000E-01
Non Drinker-vs-Weekly Drinker
7.523800E-01
Non Drinker-vs-Occasional Drinker
1.692580E-01
Non Drinker-vs-Social Drinker
7.280500E-02
Daily Drinker-vs-Weekly Drinker
7.841200E-01
Daily Drinker-vs-Occasional Drinker
1.769030E-01
Daily Drinker-vs-Social Drinker
5.233900E-02
Weekly Drinker-vs-Occasional Drinker
2.581800E-01
Weekly Drinker-vs-Social Drinker
1.701050E-01
Occasional Drinker-vs-Social Drinker
8.106600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.647600E-01
Normal-vs-Grade 2
7.566800E-01
Normal-vs-Grade 3
7.443000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.466600E-01
Grade 1-vs-Grade 3
8.422600E-01
Grade 1-vs-Grade 4
5.647600E-01
Grade 2-vs-Grade 3
7.791200E-01
Grade 2-vs-Grade 4
7.566800E-01
Grade 3-vs-Grade 4
7.443000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.312400E-01
Normal-vs-NonDiabetic
7.481600E-01
Diabetic-vs-NonDiabetic
1.046780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.781000E-01
Normal-vs-NoPancreatitis
8.140200E-01
Pancreatitis-vs-NoPancreatitis
6.149400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.745800E-01
Normal-vs-N1
9.331200E-01
N0-vs-N1
1.532190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.299200E-01
Normal-vs-TP53-NonMutant
5.151400E-01
TP53-Mutant-vs-TP53-NonMutant
2.556200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
